Recent Finacing
Recent Raise
Totient operates an AI-driven platform that mines tertiary lymphoid structures from tissue and BALF to identify tissue-specific antigens and reconstruct human antibodies for cell therapies, ADCs and bispecifics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Totient.
